Medicare Enrolled
Dr. Andrew Colman, DO
Dermatology · Westland, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Colman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Colman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Colman
Dr. Andrew Colman is a dermatology specialist in Westland, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Colman performed 2,037 Medicare services across 718 unique beneficiaries.
Between the years covered by Open Payments, Dr. Colman received a total of $7,617 from 52 pharmaceutical and/or device companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Colman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in MI
$7,617 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,037
Medicare services
Top 9% in MI for dermatology
718
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
671 | $71 | $237 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
473 | $51 | $180 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
257 | $61 | $168 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
135 | $50 | $219 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
96 | $8 | $15 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
95 | $35 | $122 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
72 | $36 | $129 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
47 | $114 | $349 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
41 | $42 | $138 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $88 | $176 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
24 | $138 | $435 |
| Nursing facility discharge management, 30 minutes or less This service covers the management of a patient's discharge from a nursing facility. It applies when the total time spent on discharge activities is 30 minutes or less. |
22 | $63 | $192 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
20 | $72 | $105 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
20 | $31 | $70 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
18 | $90 | $334 |
| Hospice care plan supervision, complex multidisciplinary Physician oversight of a patient enrolled in a Medicare-approved hospice program without the patient being present. This involves developing or revising care plans and reviewing reports for complex, multidisciplinary care needs. |
15 | $84 | $280 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,617
Total received (2018-2024)
Avg $1,088/year across 7 years
Top 7% in MI for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
456
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,537 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,279
2023
$1,173
2022
$1,427
2021
$1,364
2020
$965
2019
$1,145
2018
$263
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$186
UCB, Inc.
$91
Vanda Pharmaceuticals Inc.
$89
Otsuka America Pharmaceutical, Inc.
$84
ABBVIE INC.
$76
Abbott Laboratories
$66
Sumitomo Pharma America, Inc.
$64
E.R. Squibb & Sons, L.L.C.
$63
AstraZeneca Pharmaceuticals LP
$62
Neurocrine Biosciences, Inc.
$61
Janssen Pharmaceuticals, Inc
$60
Novo Nordisk Inc
$51
bioMerieux Inc
$48
PFIZER INC.
$41
Amgen Inc.
$35
Neurelis, Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Exact Sciences Corporation
$33
GlaxoSmithKline, LLC.
$32
Bayer Healthcare Pharmaceuticals Inc.
$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
Teva Pharmaceuticals USA, Inc.
$18
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 28.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$778
Sunovion Pharmaceuticals Inc.
$603
Teva Pharmaceuticals USA, Inc.
$590
PFIZER INC.
$577
Lilly USA, LLC
$538
Amgen Inc.
$349
Novo Nordisk Inc
$328
Bayer HealthCare Pharmaceuticals Inc.
$323
UCB, Inc.
$263
Novartis Pharmaceuticals Corporation
$260
Vanda Pharmaceuticals Inc.
$242
Boehringer Ingelheim Pharmaceuticals, Inc.
$226
Sumitomo Pharma America, Inc.
$221
E.R. Squibb & Sons, L.L.C.
$200
AstraZeneca Pharmaceuticals LP
$185
Neurocrine Biosciences, Inc.
$160
Bayer Healthcare Pharmaceuticals Inc.
$152
Otsuka America Pharmaceutical, Inc.
$138
ABBVIE INC.
$137
Abbott Laboratories
$134
GlaxoSmithKline, LLC.
$119
Biogen, Inc.
$117
Astellas Pharma US Inc
$93
Exact Sciences Corporation
$78
SANOFI-AVENTIS U.S. LLC
$76
IDORSIA PHARMACEUTICALS US INC
$74
ACADIA Pharmaceuticals Inc
$72
Xeris Pharmaceuticals, Inc.
$53
bioMerieux Inc
$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$47
Eisai Inc.
$40
Neurelis, Inc.
$35
Collegium Pharmaceutical, Inc.
$25
Horizon Therapeutics plc
$24
Circassia Pharmaceuticals Inc
$24
Lundbeck LLC
$21
DEXCOM, INC.
$20
Mylan Specialty L.P.
$20
Boston Scientific Corporation
$19
AbbVie Inc.
$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$19
CMP Pharma, Inc.
$19
Sun Pharmaceutical Industries Inc.
$18
Allergan, Inc.
$18
Dexcom, Inc.
$16
SANOFI PASTEUR INC.
$16
Scilex Pharmaceuticals Inc.
$16
Avanir Pharmaceuticals, Inc.
$15
Esperion Therapeutics, Inc.
$14
Amarin Pharma Inc.
$14
Allergan Inc.
$12
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 25.9% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · ANORO · ANORO ELLIPTA · APTIOM · AUSTEDO · Aimovig · AirDuo Digihaler · Austedo XR · BASAGLAR · BIOFIRE SPOTFIRE Respiratory (R) Panel · BREZTRI · Briviact · CAMZYOS · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · CaroSpir · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EVUSHELD · Enbrel · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fanapt · GEMTESA · GLYXAMBI · GVOKE PFS · HETLIOZ · INGREZZA · INVOKANA · JANUVIA · JARDIANCE · KAPSPARGO · KYNMOBI · Kerendia · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · MOUNJARO · MYRBETRIQ · NEXIUM · NEXLETOL · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OFEV · Otezla · Ozempic · PENNSAID · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SOLIQUA 100/33 · SPECTRA WAVEWRITER · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · UBRELVY · UTIBRON NEOHALER · VALTOCO · VRAYLAR · VYNDAQEL · Vascepa · XARELTO · XIFAXAN · XTAMPZA · Yupelri · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for dermatology in MI.
Geographic Context
Dermatologists within 10 mi
167
Per 100K population
9.4
County median income
$59,521
Nearest hospital
GARDEN CITY HOSPITAL
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Colman is a clinical cardiology specialist, with above-average Medicare volume (top 9% in MI), with low-engagement industry engagement in the top 7% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Colman experienced with nursing facility visit, moderate complexity?
Based on Medicare claims data, Dr. Colman performed 671 nursing facility visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Colman receive payments from pharmaceutical companies?
Yes. Dr. Colman received a total of $7,617 from 52 companies across 456 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Colman's costs compare to other dermatologists in Westland?
Dr. Colman's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Colman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Dermatology
Common procedures, typical costs, and what industry payments mean in dermatology.
Same specialty & city
Dermatologists in Westland
Browse dermatologists in Westland ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in MI
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in MI
Which MI dermatologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology